淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4801人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997900, encodeId=95e4199e90033, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：急性淋巴细胞白血病青少年和年轻患者究竟该按儿科还是成人方案治疗？, objectType=article, longId=140717, objectId=1828140e17a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1828140e17a4, replyNumber=0, likeNumber=69, createdTime=2018-11-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1828140e17a4, moduleTitle=Blood：急性淋巴细胞白血病青少年和年轻患者究竟该按儿科还是成人方案治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1828140e17a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997905, encodeId=28cd199e905ca, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤, objectType=article, longId=144842, objectId=fd5514484242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5514484242, replyNumber=0, likeNumber=52, createdTime=2018-12-19, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5514484242, moduleTitle=西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5514484242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997903, encodeId=d30f199e90320, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：信号通路抑制剂在高危的慢性淋巴细胞白血病中的应用, objectType=article, longId=144251, objectId=d829144251c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d829144251c8, replyNumber=0, likeNumber=78, createdTime=2018-09-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d829144251c8, moduleTitle=Blood：信号通路抑制剂在高危的慢性淋巴细胞白血病中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d829144251c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997888, encodeId=a586199e888f6, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）, objectType=article, longId=134134, objectId=96e713413423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96e713413423, replyNumber=0, likeNumber=17, createdTime=2019-01-29, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96e713413423, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96e713413423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997925, encodeId=4194199e9259f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：在ERG基因上发现急性淋巴细胞白血病的新的易感突变位点, objectType=article, longId=155306, objectId=dac615530635, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dac615530635, replyNumber=0, likeNumber=51, createdTime=2019-09-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dac615530635, moduleTitle=Blood：在ERG基因上发现急性淋巴细胞白血病的新的易感突变位点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dac615530635)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997931, encodeId=05ca199e931ca, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病, objectType=article, longId=158906, objectId=356b158906ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=356b158906ea, replyNumber=0, likeNumber=60, createdTime=2019-02-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=356b158906ea, moduleTitle=BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=356b158906ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997885, encodeId=c2af199e88511, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM： Venetoclax-Rituximab用于复发难治性慢性淋巴细胞白血病, objectType=article, longId=133114, objectId=c4d3133114d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4d3133114d2, replyNumber=0, likeNumber=59, createdTime=2018-09-10, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4d3133114d2, moduleTitle=NEJM： Venetoclax-Rituximab用于复发难治性慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4d3133114d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997889, encodeId=efde199e8893c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法, objectType=article, longId=134411, objectId=d0c11344118f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c11344118f, replyNumber=0, likeNumber=95, createdTime=2018-08-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c11344118f, moduleTitle=Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c11344118f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997913, encodeId=02c5199e9130e, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：采用依鲁替尼治疗慢性淋巴细胞白血病，一个疗程后可适当降低剂量, objectType=article, longId=149704, objectId=9346149e0490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9346149e0490, replyNumber=0, likeNumber=79, createdTime=2019-08-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9346149e0490, moduleTitle=Blood：采用依鲁替尼治疗慢性淋巴细胞白血病，一个疗程后可适当降低剂量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9346149e0490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997901, encodeId=3536199e901d7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=《中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2018年版)》解读, objectType=article, longId=141937, objectId=f08214193ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08214193ed4, replyNumber=0, likeNumber=20, createdTime=2018-07-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08214193ed4, moduleTitle=《中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2018年版)》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08214193ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997892, encodeId=6a34199e892d0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：急性淋巴细胞白血病（ALL）患者的血栓栓塞风险评估, objectType=article, longId=135597, objectId=69c613559e14, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69c613559e14, replyNumber=0, likeNumber=69, createdTime=2018-11-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69c613559e14, moduleTitle=Blood：急性淋巴细胞白血病（ALL）患者的血栓栓塞风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69c613559e14)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997891, encodeId=3654199e891d4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【盘点】急性淋巴细胞白血病近期重要研究进展汇总, objectType=article, longId=135196, objectId=876f135196e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=876f135196e8, replyNumber=0, likeNumber=56, createdTime=2018-09-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=876f135196e8, moduleTitle=【盘点】急性淋巴细胞白血病近期重要研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=876f135196e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997930, encodeId=c619199e93029, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=成人急性淋巴细胞白血病诊疗规范（2018年版）, objectType=article, longId=156787, objectId=50d7156e872a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50d7156e872a, replyNumber=0, likeNumber=16, createdTime=2019-05-02, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50d7156e872a, moduleTitle=成人急性淋巴细胞白血病诊疗规范（2018年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50d7156e872a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997928, encodeId=9f03199e928b4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, objectType=article, longId=156351, objectId=2df2156351e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df2156351e6, replyNumber=0, likeNumber=72, createdTime=2019-03-02, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df2156351e6, moduleTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2df2156351e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997926, encodeId=85cf199e92629, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性, objectType=article, longId=155391, objectId=a3ed15539185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3ed15539185, replyNumber=0, likeNumber=70, createdTime=2019-11-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3ed15539185, moduleTitle=Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3ed15539185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997920, encodeId=85f0199e92065, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=专家“亿”周谈——聚焦高危慢性淋巴细胞白血病：靶向药物与细胞免疫疗法, objectType=article, longId=154556, objectId=1abd15455646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1abd15455646, replyNumber=0, likeNumber=19, createdTime=2019-05-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1abd15455646, moduleTitle=专家“亿”周谈——聚焦高危慢性淋巴细胞白血病：靶向药物与细胞免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1abd15455646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997897, encodeId=138f199e897ae, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量, objectType=article, longId=137632, objectId=d12113e632d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12113e632d1, replyNumber=0, likeNumber=86, createdTime=2018-12-31, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12113e632d1, moduleTitle=Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12113e632d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997884, encodeId=6787199e8845b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Brit J Cancer：母亲糖尿病与子代儿童期急性淋巴细胞白血病风险！, objectType=article, longId=131244, objectId=b4bd131244f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4bd131244f4, replyNumber=0, likeNumber=60, createdTime=2019-01-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4bd131244f4, moduleTitle=Brit J Cancer：母亲糖尿病与子代儿童期急性淋巴细胞白血病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4bd131244f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997923, encodeId=c61d199e92363, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NEJM：伊布替尼用于老年慢性淋巴细胞白血病, objectType=article, longId=155107, objectId=5b1a15510e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b1a15510e83, replyNumber=0, likeNumber=61, createdTime=2019-07-12, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b1a15510e83, moduleTitle=NEJM：伊布替尼用于老年慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b1a15510e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997922, encodeId=7fe0199e92271, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2018 加拿大循证指南：慢性淋巴细胞白血病的一线治疗, objectType=article, longId=154601, objectId=e49815460121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e49815460121, replyNumber=0, likeNumber=21, createdTime=2019-01-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e49815460121, moduleTitle=2018 加拿大循证指南：慢性淋巴细胞白血病的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e49815460121)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：急性淋巴细胞白血病青少年和年轻患者究竟该按儿科还是成人方案治疗？

2018-11-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

西安杨森旗下亿珂®获批适应症扩展用于一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤

2018-12-19

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：信号通路抑制剂在高危的慢性淋巴细胞白血病中的应用

2018-09-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）

2019-01-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：在ERG基因上发现急性淋巴细胞白血病的新的易感突变位点

2019-09-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

BCL-2抑制剂Venetoclax获NICE批准用于慢性淋巴细胞白血病

2019-02-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM： Venetoclax-Rituximab用于复发难治性慢性淋巴细胞白血病

2018-09-10

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法

2018-08-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：采用依鲁替尼治疗慢性淋巴细胞白血病，一个疗程后可适当降低剂量

2019-08-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

《中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断与治疗指南(2018年版)》解读

2018-07-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：急性淋巴细胞白血病（ALL）患者的血栓栓塞风险评估

2018-11-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【盘点】急性淋巴细胞白血病近期重要研究进展汇总

2018-09-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

成人急性淋巴细胞白血病诊疗规范（2018年版）

2019-05-02

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学

2019-03-02

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet oncol：依鲁替尼联合奥比托珠单抗治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的效果和安全性

2019-11-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

专家“亿”周谈——聚焦高危慢性淋巴细胞白血病：靶向药物与细胞免疫疗法

2019-05-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量

2018-12-31

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Brit J Cancer：母亲糖尿病与子代儿童期急性淋巴细胞白血病风险！

2019-01-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NEJM：伊布替尼用于老年慢性淋巴细胞白血病

2019-07-12

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2018 加拿大循证指南：慢性淋巴细胞白血病的一线治疗

2019-01-30

科室
- - 订阅+
  - 更多科室
工具
服务